Publications

Scaling eukaryotic cell-free protein synthesis achieved with the versatile and high-yielding tobacco BY-2 cell lysate

Das Gupta M, et al. (2023)

ALiCE®: Simple reaction, radical results.

Facile scaling of eukaryotic cell-free protein synthesis from microliters to liter volumes with consistent yields

Leaving the cell behind: The Art of Biomarker Validation

European Biotechnology - Summer Edition 2019; Vol 18; 8-9.

Rapid screening and scaled manufacture of immunogenic virus-like particles in a tobacco BY-2 cell-free protein synthesis system

Tobacco BY-2 cell-free lysate: an alternative and highly-productive plant-based in vitro translation system. Tobacco BY-2 cell-free lysate…

ALiCE® – who the *piep* is ALiCE

Labor Journal, November 2022

Revolutionizing Biopharma manufacturing

LenioBio develops efficient and sustainable technologies for protein expression. With a clear goal...

Combination of two epitope identification techniques enables the rational design of soy allergen Gly m 4 mutants.

Biotechnology Journal 2017;12:1600441.

Combined 15N-Labeling and TandemMOAC Quantifies Phosphorylation of MAP Kinase Substrates Downstream of MKK7 in Arabidopsis

Frontiers in Plant Science 2017;8:2050.